2015 Annual Meeting | 8MS.001 - Attention Deficit Hyperactivity Disorder Across the Lifespan

��ɫ��

2015 Annual Meeting | 8MS.001 - Attention Deficit Hyperactivity Disorder Across the Lifespan

Date Saturday 04/25/15

Time 06:30 AM - 08:00 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Morning Seminar

Director(s) Martha B. Denckla, MD

Topic(s) Child Neurology and Developmental Neurology

Learning Objectives Participants should understand the neurobiological nature of ADHD from childhood through adulthood, the rationale for a multimodal treatment method, the "official" clinician's guidelines to diagnosis, and pharmaco Rx.

CME Available 1.50 CME credits

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge

Recommended Audience Trainee, General Neurologist, Specialist Neurologist

Teaching Styles Didactic, Audience Participation

Event Timeline
06:30 AM - 06:55 AM		ADHD: Diagnosis and Assessment Max Wiznitzer, MD, FAAN
06:55 AM - 07:20 AM		ADHD: Neurobiology and Research Martha B. Denckla, MD
07:20 AM - 07:50 AM		ADHD: Treatment Options and Issues Max Wiznitzer, MD, FAAN
07:50 AM - 08:00 AM		Questions and Answers

Faculty Disclosures
Martha B. Denckla, MD	No disclosure on file
Max Wiznitzer, MD, FAAN	Dr. Wiznitzer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Department of Health and Human Services - Vaccine Injury Compensation Program. Dr. Wiznitzer has a non-compensated relationship as a Board of Directors with CHADD that is relevant to AAN interests or activities.

��ɫ����

��ɫ����

��ɫ��

��ɫ��